 |
|
|
Advisory Committee on Immunization Practices |
|
| FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION |
|
ACIP Recommendations: Influenza |
|
|
| |
|
|
Recommendations - Influenza |
|
|
|
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
| |
Antiviral Agents for the
Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24 |
|
|
HTML | PDF |
| |
Licensure of a High-Dose
Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone
High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486 |
|
| HTML | PDF |
| |
Expansion of Use of Live Attenuated
Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other
FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November
23, 2007; 56(46):1217-1219 |
|
| HTML | PDF |
| |
Influenza Vaccination
of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16 |
|
| HTML | PDF |
| |
Using Live, Attenuated Influenza Vaccine
for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB) |
|
| HTML | PDF |
|
| This
page was reviewed on
August 21, 2012 |
|
|
|
|
|
|
|
Immunization Action Coalition • 1573 Selby Ave • St. Paul, MN 55104 |
|
tel 651-647-9009 • fax 651-647-9131 |
|
|
| |
|
|
|
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC. |
|
|
| |
| |
|
|
|
A-Z
IAC Home